Back to search

Poland· PL-100426658

Tacrolimusum Delfarma

A tacrolimus product containing tacrolimusum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC D11AH01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTacrolimusum DelfarmaATCD11AH01REGISTER NO.PL-100426658PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Tacrolimus is registered in 12 of 19 countries.

Countries holding a registration under ATC D11AH01 (tacrolimus), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Tacrolimus · ATC D11AH01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Tacrolimusum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
D11AH01
ATC class
Tacrolimus
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991416836
  • gtin
    05909991416843

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tacrolimus in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tacrolimus products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Adport, Dailiport
  • Belgium · Adoport, Dailiport
  • Bulgaria · Програф
  • Cyprus · Prograf, Tacrolimus Accord
  • Czechia · Dailiport, Gecrol
  • Germany · Crilomus, Dailiport
  • Denmark · Adport, Dailiport
  • Estonia · Dailiport, Lebsanan
  • Spain · Adoport, Cellmune
  • Finland · Adport, Adport,
  • France · Adoport, Conferoport
  • United Kingdom (Northern Ireland) · Adoport, Ascezo
  • Greece · Atodrit-Dermo, Eczatope Derm
  • Croatia · Atezyrix, Dermitopic
  • Hungary · Prograf, Tacrolimus Stada
  • Ireland · Prograf, Tacrolimus Accord
  • Iceland · Advagraf, Dailiport
  • Italy · Adoport, Carelimus
  • Liechtenstein · Advagraf, Envarsus
  • Lithuania · Dailiport, Lebsanan
  • Luxembourg · Prograft, Sumilor
  • Latvia · Dailiport, Lebsanan
  • Malta · Prograf
  • Netherlands · Adport, Conferoport
  • Norway · Adport, Advagraf
  • Portugal · Adoport, Dermitopic
  • Romania · Prograf, Tacrolimus Sandoz
  • Sweden · Adport, Adport,
  • Slovenia · Adoport, Dailiport
  • Slovakia · Atezyrix, Dailiport

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4e2bd3b8-594d-4635-b004-72491b14a1b3
GET /v1/drugs/4e2bd3b8-594d-4635-b004-72491b14a1b3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Maść",
  "source": "urpl",
  "strength": "0,1%",
  "packaging": "05909991416836 ¦ Rpz ¦ 134363\n1 tuba 10 g\n05909991416843 ¦ Rpz ¦ 134364\n1 tuba 30 g",
  "substance": null,
  "common_name": "Tacrolimusum",
  "pl_product_id": "100426658",
  "pozwolenie_nr": "381/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-10-08"
}

See everything about tacrolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.